AIM ImmunoTech (AIM) Gross Profit (2010 - 2026)
AIM ImmunoTech's (AIM) quarterly Gross Profit came in at $18000.0 in Q1 2026, up 200.0% YoY from $6000.0 in Q1 2025, and up 194.74% on a QoQ basis from -$19000.0 in Q4 2025.
AIM ImmunoTech (AIM) Gross Profit (2010 - 2026) Analysis & Trends
AIM ImmunoTech (AIM) has 17 years of Gross Profit data on file, last reported at $18000.0 in Q1 2026.
- Quarterly Gross Profit rose 200.0% year-over-year to $18000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$28000.0 (down 124.78% YoY) and the FY2025 annual result came in at -$40000.0, down 128.78% from the prior year.
- Gross Profit improved to $18000.0 in Q1 2026, from -$19000.0 in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $53000.0 in Q4 2023 to a low of -$44000.0 in Q1 2022.
- A 5-year average of $7923.1 and a median of $16000.0 in 2023 frame the typical range for Gross Profit.
- Annual changes were most pronounced in 2025 — Gross Profit sank 255.56% — and 2026, when it surged 200.0%.
- Tracing AIM's Gross Profit over 5 years: stood at -$39000.0 in 2022, then jumped by 235.9% to $53000.0 in 2023, then decreased by 28.3% to $38000.0 in 2024, then slumped by 150.0% to -$19000.0 in 2025, then jumped by 194.74% to $18000.0 in 2026.
- The last three Gross Profit figures came in at $18000.0 (Q1 2026), -$19000.0 (Q4 2025), and -$42000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | AIM ImmunoTech | 4.43 Mn | -5.53 Mn | 21,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21,000.00 |
| Jun 30, 2026 | 21,000.00 |
| Mar 31, 2026 | 18,000.00 |
| Mar 31, 2026 | 18,000.00 |
| Dec 31, 2025 | -19,000.00 |
| Dec 31, 2025 | -19,000.00 |
| Sep 30, 2025 | -42,000.00 |
| Sep 30, 2025 | -42,000.00 |
| Jun 30, 2025 | 15,000.00 |
| Jun 30, 2025 | 15,000.00 |
| Mar 31, 2025 | 6,000.00 |
| Mar 31, 2025 | 6,000.00 |
| Dec 31, 2024 | 38,000.00 |
| Dec 31, 2024 | 38,000.00 |
| Sep 30, 2024 | 27,000.00 |
| Sep 30, 2024 | 27,000.00 |
| Jun 30, 2024 | 42,000.00 |
| Jun 30, 2024 | 42,000.00 |
| Mar 31, 2024 | 32,000.00 |
| Mar 31, 2024 | 32,000.00 |